Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa

Journal of Pediatrics

Volumn 149, Issue 6, 2006, Pages

  Misra, Madhusmita ^a   Miller, Karen K ^a   Tsai, Patrika ^a   Stewart, Victoria ^a   End, Alison ^a   Freed, Natalie ^a   Herzog, David B ^a   Goldstein, Mark ^a   Riggs, Suzanne ^a   Klibanski, Anne ^a  

^a Division of Child and Adolescent Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; C REACTIVE PROTEIN; CYTOKINE; GROWTH HORMONE; INTERLEUKIN 6; LEPTIN; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ANOREXIA NERVOSA; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HYPERCORTISOLISM; PRIORITY JOURNAL; REGRESSION ANALYSIS; WEIGHT GAIN;

EID: 33751325214     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.08.043     Document Type: Article

References (50)

1. Garcia-Rubira J., Hidalgo R., Gomez-Barrado J., Romero D., and Cruz Fernandez J. Anorexia nervosa and myocardial infarction. Int J Cardiol 45 (1994) 138-140
2. Koenig W., Sund M., Frohlich M., Fischer H.-G., Lowel H., Doring A., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
3. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
4. Yeh E. CRP as a mediator of disease. Circulation 109 (2004) II-11-4
5. Paoletti R., Gotto Jr. A.M., and Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 109 (2004) III-20-6
6. Walsh D., Mahmoud F., and Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 11 (2003) 60-62
7. Sesmilo G., Miller K.K., Hayden D., and Klibanski A. Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab 86 (2001) 5774-5781
8. Golden N., Kreitzer P., Jacobson M., Chasalow F., Schebendach J., Freedman S., et al. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa. J Pediatr 125 (1994) 655-660
9. Misra M., Miller K., Bjornson J., Hackman A., Aggarwal A., Chung J., et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88 (2003) 5615-5623
10. Monteleone P., Maes M., Fabrazzo M., Tortorella A., Lin A., Bosmans E., et al. Immunoendocrine findings in patients with eating disorders. Neuropsychobiol 40 (1999) 115-120
11. Vaisman N., Hahn T., Karov Y., Sigler E., Barak Y., and Barak V. Changes in cytokine production and impaired hematopoiesis in patients with anorexia nervosa: the effect of refeeding. Cytokine 26 (2004) 255-261
12. Corcos M., Guilbaud O., Chaouat G., Cayol V., Speranza M., Chambry J., et al. Cytokines and anorexia nervosa. Psychosom Med 63 (2001) 502-504
13. Brambilla F., Monti D., and Franceschi C. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa. Psychiatry Res 103 (2001) 107-114
14. Kahl K.G., Kruse N., Rieckmann P., and Schmidt M.H. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychoneuroendocrinology 29 (2004) 13-20
15. Case T., Lemieux S., Kennedy S., and Lewis G. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 25 (1999) 187-193
16. Zak A., Vecka M., Tvrzicka E., Hruby M., Novak F., Papezova H., et al. Composition of plasma fatty acids and non-cholesterol sterols in anorexia nervosa. Physiol Res 54 (2005) 443-451
17. Weinbrenner T., Zuger M., Jacoby G., Herpertz S., Liedtke R., Sudhop T., et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia. Br J Nutr 91 (2004) 959-969
18. Misra M., Miller K., Almazan C., Ramaswamy K., Lapcharoensap W., Worley M., et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 89 (2004) 4972-4980
19. Misra M., Aggarwal A., Miller K.K., Almazan C., Worley M., Soyka L.A., et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114 (2004) 1574-1583
20. Misra M., Miller K.K., Kuo K., Griffin K., Stewart V., Hunter E., et al. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289 (2005) E373-E381
21. Kristo C., Godang K., Ueland T., Lien E., Aukrust P., Froland S., et al. Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome. Eur J Endocrinol 146 (2002) 389-395
22. Wahrenberg H., Wennlund A., and Hoffstedt J. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. Eur J Endocrinol 146 (2002) 607-611
23. Lee W., Suh J., Rhee E., Park J., Sung K., and Kim S. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch Med Res 35 (2004) 540-545
24. Ridker P., Rifai N., Cook N., Bradwin G., and Buring J. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
25. Jiang R., Schulze M.B., Li T., Rifai N., Stampfer M.J., Rimm E.B., et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among Mmen with type 2 diabetes. Diabetes Care 27 (2004) 1991-1997
26. Williams M., Williams S., Milne B., Hancox R., and Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord 28 (2004) 998-1003
27. Abate N., Vega G., and Grundy S. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis 104 (1993) 159-171
28. Fernandez V., Morales L., Molero-Conejo E., Casanova A., Campos G., Raleigh X., et al. Levels of apoproteins B, A1 and CIII as markers for cardiovascular risk in lean and obese adolescents. Invest Clin 45 (2004) 29-42
29. Misra M., Miller K., Stewart V., Hunter E., Kuo K., Herzog D., et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90 (2005) 5082-5087
30. Misra M., Miller K.K., Kuo K., Griffin K., Stewart V., Hunter E., et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289 (2005) E347-E356
31. Greulich W., and Pyle S. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. (1959), Stanford University Press, Stanford
32. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
33. Kazumi T., Kawaguchi A., Hirano T., and Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52 (2003) 1113-1116
34. Steinberger J., Steffen L., Jacobs Jr. D.R., Moran A., Hong C.-P., and Sinaiko A.R. Relation of leptin to insulin resistance syndrome in children. Obesity Res 11 (2003) 1124-1130
35. Moran A., Steffen L.M., Jacobs Jr. D.R., Steinberger J., Pankow J.S., Hong C.-P., et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 28 (2005) 1763-1768
36. Colao A., Di Somma C., Cuocolo A., Spinelli L., Acampa W., Spiezia S., et al. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis?. Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab 90 (2005) 5146-5155
37. Yudkin J., Stehouwer C., Emeis J., and Coppack S. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
38. Sesmilo G., Fairfield W.P., Katznelson L., Pulaski K., Freda P.U., Bonert V., et al. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab 87 (2002) 1692-1699
39. Soyka L.A., Misra M., Frenchman A., Miller K.K., Grinspoon S., Schoenfeld D.A., et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87 (2002) 4177-4185
40. Sanchez-Muniz F., Marcos A., and Varela P. Serum lipids and apolipoprotein B values, blood pressure and pulse rate in anorexia nervosa. Eur J Clin Nutr 45 (1991) 33-36
41. Reichenberg A., Kraus T., Haack M., Schuld A., Pollmacher T., and Yirmiya R. Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-[alpha] and IL-6 secretion. Psychoneuroendocrinology 27 (2002) 945-956
42. Shaoul R., Kessel A., Toubi E., Lanir A., Glazer O., and Jaffe M. Leptin and cytokines levels in children with failure to thrive. J Pediatr Gastroenterol Nutr 37 (2003) 487-491
43. Nishino M., Kimura T., Kanda T., Kotajima N., Yoshida A., Kuwabara A., et al. Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure. J Endocrinol Invest 23 (2000) 509-514
44. Okosun I., Choi S., Hash R., and Dever G. Apolipoprotein B, ratio of total cholesterol to HDL-C, and blood pressure in abdominally obese white and black American women. J Hum Hypertens 15 (2001) 299-305
45. Sattar N., Williams K., Sniderman A.D., D'Agostino Jr. R., and Haffner S.M. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110 (2004) 2687-2693
46. McCann B., Benjamin G., Wilkinson C., Carter J., Retzlaff B., Russo J., et al. Variations in plasma lipid concentration during examination stress. Int J Behav Med 3 (1996) 251-265
47. Tauchmanova L., Rossi R., Biondi B., Pulcrano M., Nuzzo V., Palmieri E.-A., et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87 (2002) 4872-4878
48. Ford E.S. C-reactive protein concentration and cardiovascular disease risk factors in children: Findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 108 (2003) 1053-1058
49. Bachorik P.S., Lovejoy K.L., Carroll M.D., and Johnson C.L. Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the National Health and Nutrition Examination Survey III (NHANES III). Clin Chem 43 (1997) 2364-2378
50. Hickman T.B., Briefel R.R., Carroll M.D., Rifkind B.M., Cleeman J.I., Maurer K.R., et al. Distributions and trends of serum lipid levels among United States children and adolescents Ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Preventive Medicine 27 (1998) 879-890